XBiotech Inc

Company Profile

XBiotech Inc had its IPO on 2015-04-15 under the ticker symbol XBIT.

The company operates in the Healthcare sector and Biotechnology industry. XBiotech Inc has a staff strength of 84 employees.

Stock update

Shares of XBiotech Inc opened at $4.62 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $4.62 - $4.75, and closed at $4.65.

This is a -0.64% slip from the previous day's closing price.

A total volume of 6,414 shares were traded at the close of the day’s session.

In the last one week, shares of XBiotech Inc have slipped by -2.31%.

XBiotech Inc's Key Ratios

XBiotech Inc has a market cap of $142.44 million, indicating a price to book ratio of 0.4053 and a price to sales ratio of 11.901.

In the last 12-months XBiotech Inc’s revenue was $1.98 million with a gross profit of $3.36 million and an EBITDA of $-32898000. The EBITDA ratio measures XBiotech Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, XBiotech Inc’s operating margin was -1765.3% while its return on assets stood at -8.71% with a return of equity of -11.72%.

In Q2, XBiotech Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 93.3%.

XBiotech Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-0.92 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into XBiotech Inc’s profitability.

XBiotech Inc stock is trading at a EV to sales ratio of 0.686 and a EV to EBITDA ratio of 3.9436. Its price to sales ratio in the trailing 12-months stood at 11.901.

XBiotech Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$235.14 million

Total Liabilities

$4.45 million

Operating Cash Flow

$-208000.00

Capital Expenditure

$208000

Dividend Payout Ratio

0%

XBiotech Inc ended 2024 with $235.14 million in total assets and $0 in total liabilities. Its intangible assets were valued at $235.14 million while shareholder equity stood at $229.06 million.

XBiotech Inc ended 2024 with $0 in deferred long-term liabilities, $4.45 million in other current liabilities, 268930000.00 in common stock, $-40307000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $143.39 million and cash and short-term investments were $204.77 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

XBiotech Inc’s total current assets stands at $209.51 million while long-term investments were $0 and short-term investments were $61.38 million. Its net receivables were $3.79 million compared to accounts payable of $1.82 million and inventory worth $0.

In 2024, XBiotech Inc's operating cash flow was $-208000.00 while its capital expenditure stood at $208000.

Comparatively, XBiotech Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$4.65

52-Week High

$6.69

52-Week Low

$3

Analyst Target Price

$

XBiotech Inc stock is currently trading at $4.65 per share. It touched a 52-week high of $6.69 and a 52-week low of $6.69. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $5.16 and 200-day moving average was $4.26 The short ratio stood at 13.37 indicating a short percent outstanding of 0%.

Around 3515.8% of the company’s stock are held by insiders while 1203.8% are held by institutions.